Morpheus IVF - High Success Plan Revenue and Competitors
Estimated Revenue & Valuation
- Morpheus IVF - High Success Plan's estimated annual revenue is currently $2.8M per year.
- Morpheus IVF - High Success Plan's estimated revenue per employee is $112,000
Employee Data
- Morpheus IVF - High Success Plan has 25 Employees.
- Morpheus IVF - High Success Plan grew their employee count by -14% last year.
Morpheus IVF - High Success Plan's People
Name | Title | Email/Phone |
---|
Morpheus IVF - High Success Plan Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $35.6M | 202 | 55% | N/A | N/A |
#2 | $1.2M | 12 | 0% | N/A | N/A |
#3 | $0.6M | 8 | -33% | N/A | N/A |
#4 | $2.6M | 23 | -8% | N/A | N/A |
#5 | $2.8M | 25 | -14% | N/A | N/A |
#6 | $103.2M | 516 | 26% | N/A | N/A |
#7 | $99M | 495 | 21% | N/A | N/A |
#8 | $3.8M | 30 | 20% | $411K | N/A |
#9 | $13.3M | 83 | 5% | N/A | N/A |
#10 | $1.5M | 16 | -6% | N/A | N/A |
What Is Morpheus IVF - High Success Plan?
Morpheus is the first and largest chain of Indo-German fertility centers. We are associated with a team of leading gynecologists in the country with cumulative experience of 500+ years in the field of Fertility Management. Morpheus Advantages Internationally Trained Fertility Specialists Latest State-of-the-art Equipments In house team of trained Embryologists International Quality Standards Uniform and fair pricing
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.8M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Morpheus IVF - High Success Plan News
2022-04-17 - IVF Services Market Advance Technology and Trends 2021 to ...
However, high cost, complications associated with IVF treatment, ... Development policies and plans are discussed in addition to...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 25 | N/A | N/A |
#2 | N/A | 25 | -7% | N/A |
#3 | $5M | 25 | -7% | N/A |
#4 | $3.2M | 25 | -24% | N/A |
#5 | $1.8M | 25 | -11% | N/A |